Mark Wardle

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 364 citations · Full text

Medicine, Internal Medicine, Neurology +14

Demographic and clinical factors associated with changes in employment in multiple sclerosis

Phil Moore, Katharine Harding, Hannah Clarkson et al. · Multiple Sclerosis Journal · 2013 · 145 citations

Public Health, Neurology, Employment Policy +14

Long-term outcome of paediatric-onset multiple sclerosis: a population-based study

Katharine Harding, Kate Liang, M. Cossburn et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 137 citations

Medicine, Neurology, Pediatrics +14

SGCE mutations cause psychiatric disorders: clinical and genetic characterization

Kathryn J. Peall, Daniel J. Smıth, Manju A. Kurian et al. · Brain · 2013 · 129 citations · Full text

Life Sciences, Genetics, Psychiatry +15

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia

Esther B. E. Becker, Luigi Zuliani, Rosemary Pettingill et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 116 citations · Full text

Life Sciences, Neurology, Neuroscience +8